Licensing is a transaction perimeter issue
In regulated healthcare, the ability to operate may depend on approvals attached to a legal entity, premises, named professionals, or a particular service. A buyer cannot assume that those permissions transfer with the commercial assets or survive a change in control.
The licensing analysis should therefore help define what is being acquired, which entities must remain in place, and whether completion can occur before replacement approvals are effective.
Sequence regulatory work before commitment
Early diligence should map each service and location to its licence holder, regulator, responsible individual, and renewal status. The result should feed directly into the structure, timetable, conditions, and interim operating arrangements.
- Confirm change-of-control, ownership, and notification requirements.
- Identify approvals that cannot be transferred or expedited.
- Assess continuity of reimbursement and payer arrangements.
- Plan for key clinical and compliance roles through completion.
Integrate without weakening accountability
Consolidation can centralise finance, procurement, and administration, but clinical governance and local regulatory accountability must remain clear. Integration plans should distinguish functions that can move immediately from those requiring approval, consultation, or a staged transition.
Addressing these questions before a letter of intent gives the buyer room to choose a workable structure. Addressing them after signing often turns licensing into a timetable risk with limited commercial leverage.
Discuss the implications
Speak with our advisory team about how these considerations apply to your organisation or transaction.
Contact our team